查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1972597

阿曲库铵市场：按剂型、给药途径、应用、最终用户和分销管道划分－2026-2032年全球预测

Atracurium Market by Form, Route Of Administration, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，课外活动市场价值将达到 2.5175 亿美元，到 2026 年将成长至 2.6717 亿美元，到 2032 年将达到 3.3773 亿美元，复合年增长率为 4.28%。

主要市场统计数据
基准年 2025 2.5175亿美元
预计年份：2026年 2.6717亿美元
预测年份 2032 3.3773亿美元
复合年增长率 (%) 4.28%

简要概述 Atracrium 的临床作用、药理特性以及对医院和重症监护相关人员。

阿曲库铵因其可预测的、中度的神经肌肉阻断作用以及不严重依赖肾臟或肝臟功能的代谢特性，在麻醉和重症监护领域发挥着独特而持久的作用。在复杂的外科手术和长期重症监护等因器官功能障碍而导致药物选择困难的情况下，临床医生高度重视阿曲库铵的这些药理特性。阿曲库铵起效时间和持续时间的平衡以及可靠的安全性使其尤其适用于合併多种併发症的患者群体，并已从一种小众产品发展成为许多处方集中的核心选择。

重新构想阿曲库铵在手术全期和重症监护环境中的应用：新的临床实践、监管调整和供应链转型。

由于临床实践的改变、监管的改进以及供应链的重组，非教学治疗的环境正在不断变化。临床上，神经肌肉阻断的管理正显着转向个人化，并辅以客观的监测工具和通讯协定的给药方案。这使得药物作用的可预测性和可靠的逆转方案变得特别重要，促使医疗机构优先选择那些药理特性便于剂量滴定和安全唤醒的药物。

评估美国将于 2025 年实施的关税政策对 Atracrium 的供应链、成本结构和策略製造因应措施的累积影响。

美国在2025年实施的关税政策调整，引发了人们对贸易措施对无菌注射剂（包括阿曲库林）供应和成本动态影响的关注。进口关税及相关的贸易合规成本可能会增加依赖跨境采购活性成分、添加剂或初级包装组件的製造商的准入门槛。因此，製造商和合约製造商可能会重新评估其供应基地，考虑近岸外包和供应商多元化，以降低关税风险并确保无菌生产的连续性。

详细的細項分析揭示了应用、最终用户、通路、剂型和给药途径如何影响临床选择和采购。

细分市场分析揭示了临床需求、采购行为和产品设计如何微妙地影响Atracrium的发展。按应用领域分析，需求主要集中在两个方面：重症监护和外科手术。重症监护的需求又延伸至诊断程序和人工呼吸器管理，这两者都需要为多重器官衰竭患者提供可预测且安全的缓释肌肉鬆弛剂。外科手术，包括心血管手术、一般外科手术、神经外科手术和整形外科手术，则需要快速起效、持续时间可控且蓄积量低的药物，以利于术中管理和患者快速恢復。

美洲、欧洲、中东和非洲以及亚太地区的区域趋势和跨境因素影响着采购、监管和临床部署。

区域趋势对监管预期、供应链设计和临床应用模式有显着影响。在美洲，大型医院系统的采购流程往往集中化，重点在于履行合约、确保整个网路产品的一致性以及快速补货以支援高频手术。区域法规结构要求严格的无菌标准和清晰的临床标籤，这影响製造商在合规性生产和品质系统方面的投入。

这使人们对製造商、非专利供应商和专业製造商有了策略性的观点，他们的竞争格局和合作结构会影响 Atracrium 的供应链和创新。

Atracrium 的竞争格局包括跨国製药公司、专业注射剂生产商以及众多为全球医疗机构供货的非专利药生产商。这些企业透过製造地、产品配方和包装、监管合规记录以及低温运输物流和临床支援等服务能力来区分彼此。随着製药商和医院集团双方寻求稳定供应、调整采购奖励机制以及透过培训和监测通讯协定将药品整合到处方集中，双方之间的策略合作日益普遍。

为医院采购团队、麻醉科领导和製造商提供切实可行的优先建议，以降低风险并优化临床和商业性成果。

产业领导者应采取多管齐下的方法，协调临床优先事项、营运韧性和商业性柔软性。首先，医院和采购团队应制定跨职能通讯协定，整合麻醉科、药局和供应链的观点，确保产品选择既体现临床适用性，又兼顾物流可靠性。这将有助于避免决策分散，并增强应对手术量尖峰时段和加护病房(ICU) 占用率激增的准备。同时，製造商应注重透明地披露筹资策略、批次追溯和紧急时应对计画等信息，以便客户更好地评估供应风险并做出明智的合约决策。

本报告分析的基础是稳健的研究框架，其中包括对主要和次要调查的说明、专家检验和资料三角测量技术，以确保分析的严谨性和可重复性。

本报告的分析整合了第一手定性资料和严谨的二手研究，以确保提供可靠且实用的见解。第一手研究包括对麻醉师、重症监护药剂师、医院供应链经理和法规事务专业人员进行结构化访谈，以收集他们对临床实践、采购挑战和供应商绩效的直接看法。这些访谈旨在识别影响产品选择和库存管理的实际挑战、管理重点和营运限制。

汇集临床、监管和商业性见解，为整个医疗保健系统和製药公司的决策者提供参考。

阿曲库林具有可预测的中效作用和非器官依赖性代谢，尤其适用于病情复杂的患者群体，在麻醉和重症监护的治疗方案中占据着重要的地位。这种不断变化的市场格局受到以下因素的影响：临床医生对可调节神经肌肉阻断剂的偏好、监管机构对无菌注射剂日益增长的关注，以及贸易政策和全球物流趋势变化加剧的供应链压力。这些因素共同促使临床医生、负责人和生产商需要协调一致地应对，以确保安全可靠的用药途径。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：吸引器市场：按类型划分

  • 冻干粉
    • 多剂量管瓶
    • 单剂量管瓶
  • 预填充式注射器

第九章：阿特拉克里玛市场：依管理途径

  • 静脉注射
    • Bolus注
    • 持续输注

第十章：吸引器市场：依应用划分

  • 重症监护
    • 诊断治疗
    • 人工呼吸呼吸系统护理
  • 外科手术
    • 心血管外科
    • 一般外科
    • 神经外科
    • 整形外科手术

第十一章：吸引器市场：依最终用户划分

  • 门诊手术中心
    • 医院附设中心
    • 独立中心
  • 诊所
    • 一般诊所
    • 专科诊所
  • 医院
    • 私立医院
    • 公立医院

第十二章：市集市场：依分销通路划分

  • 医院药房
    • 医院药房
    • 外包药房
  • 网路药房
    • 非处方药房
    • 处方笺药房
  • 零售药房
    • 连锁药局
    • 独立药房

第十三章：课外活动市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章：吸引器市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章：吸引物市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国中庭市场

第十七章：中国旅游景点市场

第十八章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Alkaloids Corporation
  • Baxter Healthcare
  • CF Pharma Ltd.
  • Eugia Pharma
  • Gland Pharma Limited
  • GlaxoSmithKline
  • Global Calcium
  • Hikma Pharmaceuticals
  • Hospira
  • Meitheal Pharmaceuticals
  • Neon Laboratories Ltd.
  • Shandong Boyuan Pharmaceutical Co., Ltd.
  • Synnat Pharma
  • Teva Pharmaceutical Industries
  • Teva Pharmaceutical Industries Ltd.
Product Code: MRR-9A6A6F297462

The Atracurium Market was valued at USD 251.75 million in 2025 and is projected to grow to USD 267.17 million in 2026, with a CAGR of 4.28%, reaching USD 337.73 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 251.75 million
Estimated Year [2026] USD 267.17 million
Forecast Year [2032] USD 337.73 million
CAGR (%) 4.28%

A concise orientation to atracurium's clinical role, pharmacologic profile, and strategic relevance for hospitals and critical care stakeholders

Atracurium occupies a distinct and enduring role within anesthetic and critical care practice due to its predictable intermediate neuromuscular blockade and metabolism that is largely independent of renal and hepatic function. Clinicians value these pharmacologic attributes for use in complex surgical cases and prolonged intensive care scenarios where organ dysfunction complicates agent selection. Over time, atracurium has transitioned from a niche product to a core option in many formularies because it balances onset and duration with a dependable safety profile, making it especially relevant for patient populations with comorbidities.

Beyond pharmacology, operational considerations increasingly influence atracurium selection. Hospital formularies now weigh supply chain resilience, product presentation, and compatibility with common infusion protocols as heavily as clinical efficacy. This broader lens reflects a shift in decision-making where anesthesiologists, pharmacists, and procurement leaders interact more closely to optimize both clinical outcomes and operational continuity. Consequently, understanding atracurium's clinical utility together with its supply, regulatory, and logistical context is essential for stakeholders who must align therapeutic choice with institutional priorities and changing care pathways.

Emerging clinical practices, regulatory adjustments, and supply chain transformations reshaping atracurium utilization across perioperative and critical care settings

The landscape surrounding atracurium is evolving through a combination of clinical practice shifts, regulatory refinements, and supply chain reconfiguration. Clinically, there is a pronounced movement toward individualized neuromuscular blockade management supported by objective monitoring tools and protocolized dosing strategies. This has elevated the importance of predictable drug behavior and reliable reversal options, driving institutions to prioritize agents whose pharmacologic profiles facilitate titration and safe emergence.

At the same time, regulatory environments are emphasizing quality assurance for injectable products, prompting manufacturers to invest in sterile manufacturing controls and enhanced labeling clarity. These regulatory expectations intersect with supply chain trends where lean inventories are being re-evaluated in favor of buffer strategies that protect critical care continuity. Moreover, the increasing adoption of ambulatory surgery models and expanded procedural volumes in outpatient settings are shifting consumption patterns, with implications for packaging formats and distribution approaches. Together, these forces are prompting manufacturers and health systems to innovate around product presentation, cold chain logistics, and clinician education to maintain reliable access and safe use across diverse care settings.

Assessing the cumulative impact of evolving United States tariff policies in 2025 on atracurium supply chains, cost structures, and strategic manufacturing responses

The introduction of tariff policy adjustments in the United States for 2025 has amplified attention on how trade measures influence the availability and cost dynamics of sterile injectable drugs, including atracurium. Import tariffs and related trade compliance costs can increase landed input costs for manufacturers that rely on cross-border sourcing of active pharmaceutical ingredients, excipients, or primary packaging components. As a result, manufacturers and contract producers may re-evaluate supply footprints, considering nearshoring or diversification of suppliers to mitigate tariff exposure and ensure continuity of sterile production.

In response to tariff-driven cost pressures, manufacturers may adjust commercial strategies by optimizing manufacturing efficiency, renegotiating supplier contracts, or shifting production to jurisdictions with favorable trade terms. Health systems could experience indirect effects through procurement cycles as hospitals and pharmacies seek to buffer against price volatility by consolidating purchasing, increasing reliance on long-term contracts, or expanding use of therapeutic alternatives when clinically appropriate. Importantly, tariff impacts do not occur in isolation; they interact with regulatory compliance costs, inflationary input pressures, and logistics constraints, producing a cumulative effect that requires integrated commercial planning between manufacturers, distributors, and institutional buyers.

Consequently, stakeholders should expect continued scrutiny of supply chain risk and scenario planning. Contract manufacturers and finished-dose producers that proactively communicate sourcing strategies and demonstrate supply resilience will better preserve customer confidence. At the same time, purchasers will increasingly prioritize transparency regarding origin, lot traceability, and contingency plans to manage potential disruptions arising from trade policy shifts.

Granular segmentation interpretation revealing how applications, end users, distribution channels, form factors, and administration routes drive clinical choice and procurement

Segmentation reveals the nuanced pathways through which clinical need, procurement behavior, and product design shape atracurium deployment. When analyzed by application, demand centers on two primary domains: intensive care and surgical procedures. Intensive care requirements bifurcate into diagnostic procedures and mechanical ventilation, each demanding sustained neuromuscular blockade options that are predictable and safe for patients with multi-organ compromise. Surgical procedures encompass cardiovascular surgery, general surgery, neurological surgery, and orthopedic surgery, where rapid onset, controllable duration, and minimal accumulation are central to intraoperative management and timely recovery.

Viewing the market by end user highlights the diverse operational environments where atracurium is utilized. Ambulatory surgery centers, split between hospital-affiliated centers and standalone centers, increasingly seek compact, low-waste packaging and easy-to-administer formats. Clinics, differentiated into general clinics and specialty clinics, emphasize product stability and straightforward dosing. Hospitals, comprising private and public institutions, require scalable supply, robust contract terms, and clear clinical guidelines to support high-acuity use.

Distribution channel analysis underscores the role of hospital pharmacies, online pharmacies, and retail pharmacies in shaping access. In-house hospital pharmacies and outsourced pharmacy services manage sterile compounding and inventory in acute settings. Online pharmacies, both over-the-counter and prescription-focused, affect procurement convenience for lower-acuity settings, while chain and independent retail pharmacies support outpatient transitions and perioperative medication needs. Form-based segmentation between lyophilized powder and pre-filled syringes, with lyophilized options presented as multi-dose and single-dose vials and pre-filled syringes typically packaged as single-dose syringes, influences preparation time, waste, and dosing precision. Finally, route of administration considerations focus on intravenous delivery, with clinicians choosing between bolus injection and continuous infusion approaches according to procedural requirements and patient physiology.

Taken together, these segmentation lenses provide a multi-dimensional understanding of where product improvements, packaging innovations, and distribution optimizations can most effectively reduce waste, improve safety, and align with clinician workflows.

Regional dynamics and cross-border considerations across the Americas, Europe Middle East & Africa, and Asia-Pacific shaping procurement, regulation, and clinical adoption

Regional dynamics exert a strong influence on regulatory expectations, supply chain design, and clinical adoption patterns. In the Americas, procurement processes tend to be centralized for large hospital systems, with an emphasis on contract performance, product uniformity across networks, and rapid replenishment to support high-procedure volumes. Regulatory frameworks in this region demand stringent sterility standards and clear clinical labeling, which in turn shape manufacturer investments in compliant production and quality systems.

Across Europe, the Middle East & Africa, regulatory heterogeneity and variable logistics infrastructure require adaptable supply strategies. In many markets within this combined region, local regulatory approvals and import requirements create additional steps for market entry, and differences in hospital procurement sophistication can influence the pace of adoption. Manufacturers often tailor packaging and distribution to address cold chain challenges and to ensure compliance with country-specific regulatory and reimbursement environments.

The Asia-Pacific region features a blend of mature urban centers with advanced hospital systems and rapidly developing markets where procedural volumes are expanding. Procurement models range from centralized health system purchasing to fragmented private sector procurement, and manufacturers must balance cost pressures with the need to provide stable supply and clinician support. Collectively, regional variations underscore the importance of market-specific strategies that consider regulatory timelines, distribution reliability, and local clinical practice patterns to ensure consistent access and appropriate clinical use.

Competitive and partnership landscape offering strategic perspective on manufacturers, generic suppliers, and specialty players influencing atracurium availability and innovation

The competitive environment for atracurium consists of multinational pharmaceutical firms, specialty injectable manufacturers, and a broad set of generic producers that supply institutions across global markets. These players differentiate themselves through manufacturing footprint, product formulation and packaging, regulatory compliance track record, and service capabilities such as cold chain logistics and clinical support. Strategic partnerships between manufacturers and hospital groups have become more common as both parties seek to stabilize supply, align procurement incentives, and support formulary integration with training and monitoring protocols.

Innovation in this landscape is often incremental and focused on improving delivery formats, reducing preparation complexity, and enhancing sterility assurance. Some manufacturers emphasize multi-dose vial designs to reduce per-dose costs in high-volume settings, while others prioritize single-dose vials or pre-filled syringes that minimize medication errors and preparation time in ambulatory and procedural environments. Additionally, contract manufacturing organizations and specialized sterile injectables providers play a critical role by offering capacity and redundancy, which can be decisive when primary manufacturers face production constraints.

For purchasers, evaluating suppliers involves not only product characteristics but also demonstrated reliability, transparency around supply sources, and agility in responding to demand shifts. Vendor selection increasingly factors in quality metrics, recall history, and the ability to support clinical education and stewardship programs that promote appropriate use and minimize waste.

Practical, prioritized recommendations enabling hospital procurement teams, anesthesiology leaders, and manufacturers to mitigate risk and optimize clinical and commercial outcomes

Industry leaders should adopt a multi-pronged approach that aligns clinical priorities with operational resilience and commercial flexibility. First, hospitals and procurement teams ought to formalize cross-functional protocols that integrate anesthesiology, pharmacy, and supply chain perspectives to ensure product selection reflects both clinical suitability and logistical reliability. This helps avoid fragmented decision-making and improves readiness for surgical peaks or ICU surges. In parallel, manufacturers should invest in transparent communication about sourcing strategies, lot traceability, and contingency plans so customers can better assess supply risk and make informed contracting decisions.

Second, stakeholders should prioritize product presentations that reduce preparation time and medication waste. Transitioning appropriate care settings toward single-dose, ready-to-administer formats can improve safety and operating room throughput, while multi-dose offerings remain relevant in high-volume inpatient contexts. Third, building strategic inventory buffers and diversified supplier relationships will mitigate exposure to trade policy shifts and production interruptions. Strategic contracting that balances price with service-level commitments, expedited shipping provisions, and access to safety stock will be critical.

Finally, clinical stewardship must be enhanced through education on neuromuscular monitoring and protocolized dosing to reduce overuse and adverse events. Manufacturers and healthcare organizations can collaborate to provide training and tools that support safe titration and minimize residual blockade. By aligning clinical best practices with procurement and manufacturing strategies, the sector can strengthen both patient outcomes and supply stability.

Robust research framework describing primary and secondary approaches, expert validation, and data triangulation used to ensure analytical rigor and reproducibility

The analysis underpinning this report synthesizes primary qualitative inputs and rigorous secondary validation to ensure robust and actionable findings. Primary research included structured interviews with anesthesiologists, critical care pharmacists, hospital supply chain directors, and regulatory affairs specialists to capture firsthand perspectives on clinical practice, procurement challenges, and supplier performance. These interviews were conducted to identify real-world pain points, stewardship priorities, and operational constraints that shape product selection and inventory management.

Secondary research involved systematic review of regulatory guidance, sterile manufacturing standards, and publicly available clinical literature to corroborate interview insights and contextualize practice trends. Data triangulation methods were applied to reconcile differing perspectives and to identify consistent themes across geographies and care settings. Quality controls included cross-validation of supplier claims, review of adverse event reporting trends, and assessment of packaging and administration protocols to ensure conclusions reflect both clinical realities and logistical imperatives.

Finally, content was peer-reviewed by independent clinical and supply chain experts to verify the accuracy and applicability of recommendations. This layered methodology provides decision-makers with a credible foundation for strategic planning, procurement policy development, and clinical program design.

Synthesis of clinical, regulatory, and commercial insights summarizing implications for decision-makers across healthcare systems and pharmaceutical manufacturers

Atracurium occupies a valuable niche in the therapeutic toolkit for anesthesia and critical care because of its predictable intermediate action and organ-independent metabolism, attributes that are particularly advantageous in complex patient populations. The evolving landscape is shaped by clinical preferences for titratable neuromuscular blockade, heightened regulatory focus on sterile injectables, and supply chain pressures intensified by trade policy changes and global logistics dynamics. These converging factors require coordinated responses from clinicians, procurement professionals, and manufacturers to maintain safe and reliable access.

Decision-makers should view atracurium strategy holistically, integrating evidence-based clinical protocols with procurement policies that emphasize supplier transparency and contingency capacity. Investments in monitoring technologies and clinician education will reduce variability in use and improve patient safety, while packaging innovation and distribution partnerships can address operational efficiency and waste reduction. Ultimately, aligning clinical imperatives with supply resilience will be central to ensuring that atracurium remains a dependable option across perioperative and intensive care settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Atracurium Market, by Form

  • 8.1. Lyophilized Powder
    • 8.1.1. Multi Dose Vial
    • 8.1.2. Single Dose Vial
  • 8.2. Pre-Filled Syringe

9. Atracurium Market, by Route Of Administration

  • 9.1. Intravenous
    • 9.1.1. Bolus Injection
    • 9.1.2. Continuous Infusion

10. Atracurium Market, by Application

  • 10.1. Intensive Care
    • 10.1.1. Diagnostic Procedures
    • 10.1.2. Mechanical Ventilation
  • 10.2. Surgical Procedures
    • 10.2.1. Cardiovascular Surgery
    • 10.2.2. General Surgery
    • 10.2.3. Neurological Surgery
    • 10.2.4. Orthopedic Surgery

11. Atracurium Market, by End User

  • 11.1. Ambulatory Surgery Centers
    • 11.1.1. Hospital Affiliated Centers
    • 11.1.2. Standalone Centers
  • 11.2. Clinics
    • 11.2.1. General Clinics
    • 11.2.2. Specialty Clinics
  • 11.3. Hospitals
    • 11.3.1. Private Hospitals
    • 11.3.2. Public Hospitals

12. Atracurium Market, by Distribution Channel

  • 12.1. Hospital Pharmacies
    • 12.1.1. In-House Pharmacy
    • 12.1.2. Outsourced Pharmacy
  • 12.2. Online Pharmacies
    • 12.2.1. Otc Pharmacies
    • 12.2.2. Prescription Pharmacies
  • 12.3. Retail Pharmacies
    • 12.3.1. Chain Pharmacies
    • 12.3.2. Independent Pharmacies

13. Atracurium Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Atracurium Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Atracurium Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Atracurium Market

17. China Atracurium Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Alkaloids Corporation
  • 18.6. Baxter Healthcare
  • 18.7. CF Pharma Ltd.
  • 18.8. Eugia Pharma
  • 18.9. Gland Pharma Limited
  • 18.10. GlaxoSmithKline
  • 18.11. Global Calcium
  • 18.12. Hikma Pharmaceuticals
  • 18.13. Hospira
  • 18.14. Meitheal Pharmaceuticals
  • 18.15. Neon Laboratories Ltd.
  • 18.16. Shandong Boyuan Pharmaceutical Co., Ltd.
  • 18.17. Synnat Pharma
  • 18.18. Teva Pharmaceutical Industries
  • 18.19. Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ATRACURIUM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ATRACURIUM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ATRACURIUM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ATRACURIUM MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ATRACURIUM MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ATRACURIUM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ATRACURIUM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ATRACURIUM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ATRACURIUM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ATRACURIUM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ATRACURIUM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ATRACURIUM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ATRACURIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ATRACURIUM MARKET SIZE, BY MULTI DOSE VIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ATRACURIUM MARKET SIZE, BY MULTI DOSE VIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ATRACURIUM MARKET SIZE, BY MULTI DOSE VIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ATRACURIUM MARKET SIZE, BY SINGLE DOSE VIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ATRACURIUM MARKET SIZE, BY SINGLE DOSE VIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ATRACURIUM MARKET SIZE, BY SINGLE DOSE VIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ATRACURIUM MARKET SIZE, BY PRE-FILLED SYRINGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ATRACURIUM MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ATRACURIUM MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ATRACURIUM MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ATRACURIUM MARKET SIZE, BY BOLUS INJECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ATRACURIUM MARKET SIZE, BY BOLUS INJECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ATRACURIUM MARKET SIZE, BY BOLUS INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ATRACURIUM MARKET SIZE, BY CONTINUOUS INFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ATRACURIUM MARKET SIZE, BY CONTINUOUS INFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ATRACURIUM MARKET SIZE, BY CONTINUOUS INFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ATRACURIUM MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ATRACURIUM MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ATRACURIUM MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ATRACURIUM MARKET SIZE, BY MECHANICAL VENTILATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ATRACURIUM MARKET SIZE, BY MECHANICAL VENTILATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ATRACURIUM MARKET SIZE, BY MECHANICAL VENTILATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ATRACURIUM MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ATRACURIUM MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ATRACURIUM MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ATRACURIUM MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ATRACURIUM MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ATRACURIUM MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ATRACURIUM MARKET SIZE, BY NEUROLOGICAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ATRACURIUM MARKET SIZE, BY NEUROLOGICAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ATRACURIUM MARKET SIZE, BY NEUROLOGICAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ATRACURIUM MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ATRACURIUM MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ATRACURIUM MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ATRACURIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ATRACURIUM MARKET SIZE, BY HOSPITAL AFFILIATED CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ATRACURIUM MARKET SIZE, BY HOSPITAL AFFILIATED CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ATRACURIUM MARKET SIZE, BY HOSPITAL AFFILIATED CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ATRACURIUM MARKET SIZE, BY STANDALONE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ATRACURIUM MARKET SIZE, BY STANDALONE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ATRACURIUM MARKET SIZE, BY STANDALONE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ATRACURIUM MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ATRACURIUM MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ATRACURIUM MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ATRACURIUM MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ATRACURIUM MARKET SIZE, BY GENERAL CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ATRACURIUM MARKET SIZE, BY GENERAL CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ATRACURIUM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ATRACURIUM MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ATRACURIUM MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ATRACURIUM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ATRACURIUM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ATRACURIUM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ATRACURIUM MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ATRACURIUM MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ATRACURIUM MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ATRACURIUM MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ATRACURIUM MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ATRACURIUM MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ATRACURIUM MARKET SIZE, BY IN-HOUSE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ATRACURIUM MARKET SIZE, BY IN-HOUSE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ATRACURIUM MARKET SIZE, BY IN-HOUSE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ATRACURIUM MARKET SIZE, BY OUTSOURCED PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ATRACURIUM MARKET SIZE, BY OUTSOURCED PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ATRACURIUM MARKET SIZE, BY OUTSOURCED PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ATRACURIUM MARKET SIZE, BY OTC PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ATRACURIUM MARKET SIZE, BY OTC PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ATRACURIUM MARKET SIZE, BY OTC PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL ATRACURIUM MARKET SIZE, BY PRESCRIPTION PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ATRACURIUM MARKET SIZE, BY PRESCRIPTION PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ATRACURIUM MARKET SIZE, BY PRESCRIPTION PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ATRACURIUM MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ATRACURIUM MARKET SIZE, BY CHAIN PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ATRACURIUM MARKET SIZE, BY CHAIN PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL ATRACURIUM MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL ATRACURIUM MARKET SIZE, BY INDEPENDENT PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL ATRACURIUM MARKET SIZE, BY INDEPENDENT PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL ATRACURIUM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS ATRACURIUM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS ATRACURIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS ATRACURIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA ATRACURIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA ATRACURIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA ATRACURIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA ATRACURIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA ATRACURIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA ATRACURIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE ATRACURIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE ATRACURIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE ATRACURIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST ATRACURIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 198. MIDDLE EAST ATRACURIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST ATRACURIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA ATRACURIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA ATRACURIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA ATRACURIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 245. GLOBAL ATRACURIUM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN ATRACURIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN ATRACURIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN ATRACURIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 259. ASEAN ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 260. ASEAN ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 261. ASEAN ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 262. GCC ATRACURIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 263. GCC ATRACURIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 264. GCC ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 265. GCC ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 266. GCC ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
  • TABLE 267. GCC ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 268. GCC ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 269. GCC ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 270. GCC ATRACURIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 271. GCC ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 272. GCC ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 273. GCC ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 274. GCC ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 275. GCC ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 276. GCC ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 277. GCC ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION ATRACURIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION ATRACURIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPEAN UNION ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPEAN UNION ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPEAN UNION ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPEAN UNION ATRACURIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 288. EUROPEAN UNION ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 289. EUROPEAN UNION ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 290. EUROPEAN UNION ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 291. EUROPEAN UNION ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 292. EUROPEAN UNION ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 293. EUROPEAN UNION ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 294. BRICS ATRACURIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 295. BRICS ATRACURIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 296. BRICS ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 297. BRICS ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 298. BRICS ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
  • TABLE 299. BRICS ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 300. BRICS ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 301. BRICS ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 302. BRICS ATRACURIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 303. BRICS ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 304. BRICS ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 305. BRICS ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 306. BRICS ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 307. BRICS ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 308. BRICS ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 309. BRICS ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 310. G7 ATRACURIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 311. G7 ATRACURIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 312. G7 ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 313. G7 ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 314. G7 ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
  • TABLE 315. G7 ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 316. G7 ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 317. G7 ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 318. G7 ATRACURIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 319. G7 ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 320. G7 ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 321. G7 ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 322. G7 ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 323. G7 ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 324. G7 ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 325. G7 ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 326. NATO ATRACURIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 327. NATO ATRACURIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 328. NATO ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 329. NATO ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 330. NATO ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
  • TABLE 331. NATO ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 332. NATO ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 333. NATO ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 334. NATO ATRACURIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 335. NATO ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 336. NATO ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 337. NATO ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 338. NATO ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 339. NATO ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 340. NATO ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 341. NATO ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 342. GLOBAL ATRACURIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 343. UNITED STATES ATRACURIUM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 344. UNITED STATES ATRACURIUM MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 345. UNITED STATES ATRACURIUM MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 346. UNITED STATES ATRACURIUM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 347. UNITED STATES ATRACURIUM MARKET SIZE, BY INTRAVENOUS, 2018-2032 (USD MILLION)
  • TABLE 348. UNITED STATES ATRACURIUM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 349. UNITED STATES ATRACURIUM MARKET SIZE, BY INTENSIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 350. UNITED STATES ATRACURIUM MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 351. UNITED STATES ATRACURIUM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 352. UNITED STATES ATRACURIUM MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 353. UNITED STATES ATRACURIUM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 354. UNITED STATES ATRACURIUM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 355. UNITED STATES ATRACURIUM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 356. UNITED STATES ATRACURIUM MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 357. UNITED STATES ATRACURIUM MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 358. UNITED STATES ATRACURIUM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 359. CHINA ATRACURIUM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 360. CHINA ATRACURIUM MARKET SIZ